Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time read with Code of Prohibition of Insider Trading of the Company, Kilitch Drugs (India) has informed that the Trading Windows for dealing in Securities of the Company will remain closed for all the Designated Persons of the Company and their immediate relatives with effect from Wednesday, 1st April, 2026 till the expiry of 48 hours after the declaration of Financial Results of the Company for the quarter and year ended 31st March, 2026. The date of meeting of Board of Directors to approve the audited financial results of the Company for the quarter and year ended 31st March, 2026 shall be intimated in due course
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: